Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More


Merck & Co. is in superior talks to amass Seagen and is aiming to agree on a purchase of the most cancers biotech within the subsequent few weeks, in accordance with folks conversant in the matter, in a deal that may very well be value roughly $40 billion or extra.

The businesses are discussing a worth for Seagen above $200 a share and are in search of to seal a deal on or earlier than the announcement of Merck’s quarterly earnings, set for July 28, the folks stated. Seagen’s inventory closed at $175.13 on Wednesday.


Please enter your comment!
Please enter your name here

Share post:




More like this

ChatGPT acquired 100 million active users faster than TikTok and Instagram

ChatGPT, the artificial intelligence-powered...

Manhunt For Dating App Torturer Ends With Discovery Of Multiple Dead Bodies

The excellent news is, this manhunt is over....

Understanding Brain’s Response to Chronic Stress!

Scientists on the Medical Faculty of Georgia at...

It Sure Does Sound Like Biden Steamrolled Kevin McCarthy In Their Meeting

Speaker Kevin McCarthy was speaking an enormous recreation...